Key Points

• Surveillance for acute respiratory infections has begun, but no outbreaks of influenza or bronchiolitis have been observed so far in the Auvergne-Rhône-Alpes region;
• The impact of COVID-19 is moderate and significantly lower than during the same period last year;
• SARS-CoV-2 and rhinovirus are actively circulating, without a significant impact on hospital admissions, and influenza A virus has been detected sporadically;
• The start of vaccination campaigns against influenza, COVID-19, and respiratory syncytial virus infections should encourage healthcare professionals to recommend these vaccinations to affected patients.